Vivoryon Therapeutics AG(GB:0R3M)
€0.74-0.01 (-1.06%)
GB:0R3M
Vivoryon Therapeutics AG financials statements
€0.74
At close:-0.01 (-1.06%)
Vivoryon Therapeutics AG (0R3M) Financial Statements
2 Followers
Vivoryon Therapeutics AG Financial Overview
Vivoryon Therapeutics AG's market cap is currently €22.74M. The company's EPS TTM is €-0.23; its P/E ratio is -3.34; and it has a dividend yield of 2.50%. Vivoryon Therapeutics AG has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € 0.00 | € 0.00 | € -3.62M | € 0.00 | € 10.76M |
| Gross Profit | € -147.00K | € -147.00K | € -3.10M | € -161.00K | € 9.03M |
| Operating Income | € -9.18M | € -20.96M | € -28.84M | € -29.13M | € -12.81M |
| EBITDA | € -9.03M | € -20.34M | € -28.35M | € -28.17M | € -12.03M |
| Net Income | € -8.85M | € -20.57M | € -28.34M | € -28.16M | € -12.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 5.62M | € 9.37M | € 28.58M | € 26.55M | € 14.66M |
| Total Assets | € 7.52M | € 11.28M | € 30.83M | € 31.38M | € 24.52M |
| Total Debt | € 108.00K | € 102.00K | € 38.00K | € 132.00K | € 224.00K |
| Net Debt | € -5.51M | € -9.26M | € -18.52M | € -26.42M | € -14.44M |
| Total Liabilities | € 2.79M | € 3.40M | € 4.55M | € 4.87M | € 7.96M |
| Stockholders' Equity | € 4.73M | € 7.88M | € 26.28M | € 26.51M | € 16.56M |
| Cash Flow | |||||
| Free Cash Flow | € -8.46M | € -19.18M | € -22.05M | € -21.81M | € -11.29M |
| Operating Cash Flow | € -8.46M | € -19.17M | € -21.54M | € -21.79M | € -11.26M |
| Investing Cash Flow | € -6.00K | € 10.00M | € -10.51M | € -13.00K | € -28.00K |
| Financing Cash Flow | € 4.71M | € -57.00K | € 24.16M | € 33.38M | € -827.00K |
Currency in EUR
